Well, good morning, everybody, and welcome to the QinetiQ full year 2024 results. So my name is Stephen Lamacraft. I am the Interim Group Director of Investor Relations, and I'm joined with our Group CEO, Steve Wadey, and our Interim Group CFO, Heather Cashin. What we'll do is we'll start off with a run-through of the presentation with Steve and Heather, and then we'll go to Q&A. Steve, over to you. Thank you, Steven, and good morning. Welcome, everybody, to our results for FY 2024. Thank you for joining us here today. I'd like to start by thanking our incredible people. The world is experiencing the highest threat environment for a generation, and our teams across the world have worked in partnership with our customers and suppliers to deliver a strong overall group performance. The conflicts in Ukraine, the Middle East, and rising tensions with China are driving significant changes in modern warfare. As a consequence, our customers are increasing spending in critical areas of technology and innovation to stay ahead of the threat. With our partner, Oshkosh, this picture shows our Robotic Combat Vehicle system undergoing testing and experimentation at Fort Irwin in the summer last year. This next-generation autonomous system will increase situational awareness and military effectiveness for the U.S. Army against future threats. Innovation and cutting-edge technology is what we do. Our mission-critical services and products are highly aligned with national defense and security priorities. We have a clear strategy delivering enduring value for our customers and shareholders. Our agenda today is as follows: I'll start by giving you a year in review. Heather, our Interim Group CFO, will provide a commentary on our financial results. She was previously our group financial controller, and we've worked together for over six years. Heather is providing continuity until Martin Cooper joins at the end of the summer. Finally, I'll come back and give you our strategic outlook. We'll then open up for questions. First of all, our year in review. Let's look at our three key headlines. First of all, I'm really pleased that we have delivered strong group financial results for FY 2024, modestly ahead of our guidance, which have been achieved against the background of more difficult market conditions in the U.S. Secondly, we enter this year with strong momentum and increasing spending in our major markets, which gives us confidence to increase our guidance for FY 2025 compared to our result for FY 2024, and underpins the delivery of our GBP 2.4 billion organic revenue at approximately 12% margin by FY 2027. And finally, with a strengthened balance sheet and an enhanced focus on disciplined capital allocation, we have optionality for additional investment in growth and further shareholder returns. In summary, we are well positioned and have a clear strategy to deliver attractive returns and create sustainable shareholder value. Moving on to the financial highlights. We've achieved a record order intake at GBP 1.74 billion, with a book-to-bill of 1.1 and a strong order backlog. Revenue is up 21% through good program execution, up 14% on an organic basis. Operating profit is up 20%, with a stable margin of 11.3%, up 16% on an organic basis. Cash performance remains strong, with high conversion at 104%, reducing our leverage from 0.8 to 0.5 times. We delivered continued strong earnings growth, with underlying earnings per share up 11% to 29.4 pence. Return on capital employed was maintained above the upper end of our guidance at 21%, and we're increasing the growth of our progressive dividend from 5% to 7%, with a full-year dividend for FY 2024 of GBP 0.0825 and launched a GBP 100 million share buyback program. I'll now look at our performance in each of our operating segments. EMEA Services delivered excellent revenue growth at stable margin, driven by execution of high prior year orders and responding to our customers' immediate needs. We achieved a number of significant operational milestones. Our program to accelerate production of mission data and improve the protection of all UK military platforms delivered three months early. We demonstrated our world-leading laser-directed energy technology with the first firing against aerial targets in the UK. This system is now being accelerated onto Royal Navy warships from 2027. In Australia, we successfully integrated the Air Affairs business, which is performing well, with 20% more flying hours and 90% more aerial target missions than originally planned. We also made strategic progress on our Long-Term contracts. In Australia, we secured a three-year extension to our Major Service Provider contract, winning AUD 87 million of new orders for critical land and munition programs. We are on track to secure the Long Term Partnering Agreement five-year extension through to 2033, continuing in our role as UK MOD's strategic partner for test and evaluation. Our Engineering Delivery Partner contract delivered significant benefits for our UK customers, with GBP 472 million of new orders, including commencing work on the new AUKUS submarine. These are just a few of many highlights where we are delivering critical capabilities for enduring national and defense and security priorities, underpinning our sustainable growth. Global Solutions continued to be impacted by a difficult U.S. market, due to one of the longest and deepest continuing resolutions on record. Revenue was lower than expected at stable margin. Within this context, we achieved a number of significant milestones. We offset the planned ramp down of the CRS-I robotic program by delivering the highest ever production levels of our aerial targets. Our Banshee target was certified for the U.S. market, opening the door to significant opportunities to leverage our capabilities globally. Whilst Avantus declined over the whole year, the business did achieve modest growth in the second half, with double-digit margin and 100% cash conversion. Importantly, Avantus won $977 million of awards, achieving a funded Book-to-Bill of just over 1.2, giving us good revenue visibility for the years ahead. Our most strategic achievement was fully integrating Avantus to build our U.S. platform and leverage market opportunities. The benefits of integration are now being realized, demonstrated by winning $1.3 billion of total contract awards in the U.S. Our largest U.S. orders were three 5-year programs that provide high-value engineering services and mission support for the Space Development Agency, Strategic Capabilities Office, and the Tethered Aerostat Radar System, known as TARS for Homeland Security. TARS is a really great example of a contract that would not have been won without our integrated U.S. platform, and all of these three programs have significant on-contract growth potential. In addition, we have strengthened our business development team, who have qualified a multi-billion-dollar pipeline of opportunities that are directly aligned with the new U.S. National Defense Strategy. With the integration of Avantus complete, our U.S. business is well positioned to drive synergies and deliver a significant contribution to our sustainable growth over the coming years. I'll now hand over to Heather to take us through our financial results. Thank you, Steve, and good morning, everyone. Firstly, our key financial highlights. In FY 2024, we've delivered record order intake of GBP 1.74 billion, growth on a strong comparator last year. This demonstrates continued high demand for our distinctive offerings. Strong revenue at GBP 1.91 billion, growing 21% on a reported basis, delivered through good program execution across all our major contracts. Good underlying operating profit from segments at GBP 215 million, growing 20% on a reported basis at a consistent margin of 11.3%. High levels of cash conversion at 104%, contributing to leverage falling to 0.5 times. Underlying basic earnings per share of GBP 0.294 increased by 11% due to our excellent operational performance, offset by a higher effective tax rate in the UK and interest expense. Finally, return on capital employed. We're pleased to see another strong year of performance, marginally ahead of our guidance, delivering 21%. Overall, a strong group result in FY 2024, which is a good foundation to deliver our future ambition and guidance. Moving on to orders. We've delivered a good order performance in the period against a strong order intake last year. In FY 2023, we booked the 10-year Maritime Strategic Capability Agreement, or MSCA, for GBP 260 million. This was a significant in-year one-off. Organically, orders declined 10% year-on-year. Excluding the MSCA, orders grew 7%. Order performance of GBP 204 million from acquisitions and disposals includes the contribution from Avantus and Air Affairs and the disposal of Space NV on a comparative basis to the prior financial year. For FY 2024, including the impact of acquisitions, order growth was 19% for the year, excluding MSCA, and 1%, including the MSCA. If we look to the charts on the right, at the top, we can see orders won by size. We continue to book orders on both smaller and larger contracts.... Given our larger US footprint, we've expanded our disclosure in line with normal US practice. In the US, orders are won and subsequently funding is released. We book the funded amount in each year in the orders number. The box highlights contract awards for which funding has not yet been appropriated or authorized. An example of this is the TARS contract that Steve mentioned earlier. The total contract was $170 million. We booked GBP 16 million in FY 2024, and the remaining contract value we expect to be funded by the customer and booked in future years. The chart on the bottom right highlights that we closed FY 2024 with a strong funded order backlog of GBP 2.9 billion, with an additional U.S. unfunded backlog of GBP 0.8 billion, bringing the total to GBP 3.7 billion. The U.S. unfunded backlog and the overall book-to-bill of 1.1x gives us great visibility into our future growth. We've delivered strong revenue at GBP 1.9 billion, growing 21% or 14% on an organic constant currency basis, demonstrating increasing demand for our six distinctive offerings. This has been driven by increased delivery across our EMEA Services major contracting frameworks. Global solutions was down GBP 11 million, which I'll come back to later. Acquisitions and disposals are shown as partial year contributions to give an accurate year-on-year comparison. This reflects the comparator contribution from Air Affairs, Avantus, and the disposal of Space NV. As the chart on the right highlights, we end FY 2024 with 64% of our FY 2025 revenue under contract, compared to 61% at the same point last year, helping to underpin our confidence in the year ahead. The U.S. unfunded orders of 6% represent contract awards, which are expected to be funded in FY 2025. We've delivered strong underlying operating profit from segments at GBP 215.2 million, which represents an increase of 20% or 16% on an organic constant currency basis. This is an 11.3% operating profit margin, consistent with our guidance range of 11%-12%, demonstrating sustainable revenue growth at stable margin. The largest contributions to year-on-year growth were the full year impact of the Avantus acquisition and organic revenue growth at stable operating margins within EMEA Services. On the right, you'll see a table reconciling underlying operating profit from segments to statutory operating profit. If I take these one by one, income from research and development expenditure credits, or RDEC, increased in FY 2024 due to an increase in the rate paid from 13% to 20%. Amortization of intangibles has increased year-on-year, reflecting the intangibles acquired through Avantus and Air Affairs. Acquisition costs have reduced, and in FY 2024 are primarily driven by the integration costs for Avantus and Air Affairs. We expect this number to be significantly lower in FY 2025 as we focus on organic growth. The digital platform represents a discrete multi-year investment project to enable our global growth strategy and our AUKUS customer needs. We expect approximately GBP 35 million of additional costs over the next three years, which will fade through to completion. The cost here reflects the implementation costs previously accounted for as CapEx before the SaaS accounting changes. All recurring costs, such as licenses and maintenance, are reported within the underlying cost base. Within other, in FY 2023, we also reported a one-off adjustment pertaining to the decision from UK government to allow companies to keep the RDEC benefits. This does not repeat in FY 2024. Now, turning to the segmental split of group performance. First, we have EMEA Services. Orders saw 7% growth, excluding the impact of MSCA. When including MSCA, orders saw a 13% decline. We secured GBP 1.2 billion of orders, including GBP 472 million from the engineering delivery partnership framework. We also achieved a variation on price uplift on the LTPA, an extension to our Battlefield and Tactical Communications and Information Systems, or BATCIS contract, and a significant multi-year aerial training targets services contract in Germany. Revenue growth was strong at 20%, driven by our UK sectors, which were underpinned by execution of the EDP framework and inflation uplifts. Operating profit grew in line with revenue at 19%, and margins remained stable at 11.5% in FY 2024. EMEA Services has a funded order backlog of GBP 1.4 billion, excluding the LTPA, and a book-to-bill ratio of 1.04 times, compared to 1.17 times, excluding MSCA in FY 2023. Next, on to global solutions. Total orders grew 56%, driven by the full-year contribution of Avantus. Orders grew 7% on an organic basis. As explained earlier, strong US unfunded orders of $578 million support our confidence and visibility in Global Solutions.... Global Solutions overall saw 23% revenue growth, with a small organic decline of 3%. As Steve mentioned earlier, we were impacted by the continuing resolution in the US and a planned ramp down in projects coming to an end. Global Solutions, excluding Avantus, delivered broadly flat revenue due to the decline in revenue from the CRS-I ramp down, offset by the highest ever production levels in QinetiQ Target Systems. Avantus saw a high single-digit organic revenue decline over the course of the year and a modest revenue growth in H2 versus H1. Despite these headwinds, we've delivered double-digit operating profit margins of 10.5%, with double-digit margins in both Global Solutions and Avantus. We have a strong funded backlog of GBP 321 million, further supported by our unfunded backlog from contract awards not yet authorized and appropriated. Our book-to-bill ratio of 1.1x and Avantus' book-to-bill ratio of 1.2x gives us confidence heading into FY 2025 and beyond. Now, if we move to cash, we've delivered excellent underlying net cash flow from operations at GBP 320 million, materially, materially ahead of guidance, which equates to a cash conversion ratio of 104%. This cash conversion is as a result of our strong underlying cash performance and continued focus and discipline on working capital management. We've invested GBP 96 million in capital expenditure, investing in infrastructure improvements and capability enhancements. GBP 37 million of this relates to investments in the LTPA, reduced from the prior year. The LTPA CapEx is funded through the contract, which means that although QinetiQ funds upfront investment, it is paid back through the depreciation over the life of the contract. A key component of delivering our strategic ambition is to have a robust financial framework that ensures efficient use of our balance sheet. Our net debt position improved from GBP 207 million to GBP 151 million through the year, as we saw strong cash conversion and working capital management, particularly in the second half. In FY 2024, we also returned GBP 62 million to shareholders in the form of dividends and buybacks, with GBP 16 million of the GBP 100 million buyback being executed during FY 2024. We continue to see a buyback as being a compelling component of shareholder return. Following a year of strong cash generation, prudent investment in the business, and the introduction of the share buyback program, we're pleased to end the year with a leverage ratio of 0.5 times, an improvement from 0.8 times last year. This gives us flexibility for growth and enables the potential for future shareholder returns. Following this strong set of results, we're increasing our FY 2025 guidance and are on track to deliver our FY 2027 outlook. We enter FY 2025 with strong momentum, a healthy order book, and increased visibility, with 64% revenue under contract. We expect FY 2025 to deliver high single-digit organic revenue growth compared to FY 2024 at a stable operating profit margin. We are on track to deliver GBP 2.4 billion of organic revenue at approximately 12% margin by FY 2027. This will deliver an attractive return on capital, capital employed at or above the upper end of the 15%-20%+ range. Cash conversion will remain high at 90%+, with capital expenditure within the GBP 90-120 million range. Our strengthened balance sheet provides optionality through disciplined deployment of capital for bolt-on acquisitions to compound growth at 11%-12% margin and further shareholder returns. Thank you. Back to you, Steve. Great job, Heather. Thank you. So now let me take you through our strategic outlook. The world is experiencing the highest and most rapidly evolving threat environment for a generation. Russian forces remain entrenched within Ukraine. In the Middle East, the Israel-Hamas conflict is ongoing, and tensions continue to rise with China. As a result, Australia, the U.K., and the U.S. are increasing spending over the long term and focused on developing next-generation capabilities and having greater collaboration. In the U.S., the defense budget for research and development, R&D, and test and evaluation, T&E, is the largest ever at $145 billion. The U.K. and Australia have committed to approximately 2.5% of GDP, with the U.K. increasing R&D to more than 5% of a growing defense budget. Their evolving capability and investment priorities are driving increasing spending to build resilience and achieve technological superiority in our areas of strength. These areas include R&D, T&E, training and mission rehearsal, and cyber and intelligence. Our strategy and unique value proposition enables our customers to rapidly create, test, and use capability to stay ahead of this threat. By aligning our distinctive offerings to their areas of high-priority spending, we are well-positioned to continue to grow sustainably into our addressable market, worth more than GBP 30 billion per year. Within this geopolitical context, we are a differentiated company driven by our purpose: protecting lives by serving the national security interests of our customers. This has never been more relevant. Since launching our strategy in 2016, we have been building a disruptive and integrated global defense and security company uniquely relevant to modern warfare. Our track record has been achieved through disciplined execution of our strategy to ensure we build our global platform coherently with sustainable growth and attractive returns. We have increased revenue by more than 2.5 times, stabilized margin, and doubled earnings. By focusing on our customers' needs and partnering with industry, we have won larger, longer-term programs, expanding our revenue visibility and securing an order backlog of GBP 3.7 billion, including GBP 0.8 billion of U.S. unfunded backlog, as Heather described earlier. We also have an exceptionally robust pipeline of future growth opportunities, worth more than GBP 11 billion over the next 5 years. A current example is the entry into the U.S. market with our differentiated threat representation capabilities. Our strategy and distinctive offerings are uniquely relevant and aligned to our customers' needs, underpinning confidence in our ability to continue delivering organic growth at double the rate of national defense budgets. In order to stay, in order to stay relevant for the long term, we remain focused on building our global platform to deliver for our AUKUS customers and their allies. In April, I made three key appointments to our leadership team: Martin Cooper as Group CFO, Ian Stevenson as Chief Operating Officer, and Will Blamey as Chief Exec UK Defense. These changes strengthen our capability as we continue to scale and grow globally. In delivering for our customers, the single biggest contributor will be our people. We've made significant progress creating an environment where they can all thrive, with our highest ever level of employee engagement. To stay at the forefront of cutting-edge technology and innovation, we continue to invest approximately GBP 20 million per year in research and development aligned to their customer priorities, such as trusted AI. To deliver for our customers and generate even greater returns for our shareholders, we leverage our skills and products across the company through collaboration. A great example is the transfer of our unique T&E skills from the UK to build sovereign T&E capability in Australia. Last month, our AUKUS customers began consultation with industry on new regulations to support greater pooling and sharing of their resources by improving the exchange of technology and information. While these changes will take time to come into effect, they will be a significant shift for our industry. The investment in our digital platform that Heather described earlier will enable us to benefit from these changes by increasing collaboration to create more value for our customers and support further growth. The fundamentals of our strategy are robust, enabling our AUKUS customers to deliver their evolving capability and investment priorities. Let me give you four examples where their priorities, shown on the left, are driving increasing spending in our areas of core strength: R&D, T&E, training and mission rehearsal, and cyber and intelligence. The proliferation of drones, as we've seen in Ukraine, is driving the need for laser-directed energy weapons with low cost per shot and unlimited resupply. These next-generation systems are as a result of long-term R&D into disruptive technologies, as seen by our pivotal role in the DragonFire program. Capability modernization, such as the new Australian submarine program, is driving the need for state-of-the-art physical and digital T&E to share information and assure sovereignty, leveraging our world-leading role in test and evaluation. The need to maintain operational edge requires training and mission rehearsal against highly representative threat scenarios. As a global leader in airborne training and targets, we are seeing increasing demand. Finally, modern warfare requires an edge in the cyberspace to enable superiority in the battle space. As an embedded partner of scale in the UK and now also in the US, we have a critical role to support our defense and intelligence customers with our cyber and data intelligence solutions. Building on our successful performance and increasing relevance to our AUKUS customer's mission, our strategy is on track to deliver GBP 2.4 billion of organic revenue at approximately 12% margin by FY 2027. Our strategy is underpinned by our enhanced focus on disciplined capital allocation and execution. As a highly cash-generative business, we deploy our capital consistently with our policy to deliver value-accretive investments and attractive returns for shareholders, while maintaining a prudent balance sheet. During the year, we've decided to increase shareholder returns. In January, we launched a GBP 100 million share buyback program, which is on track, and today we've announced an increase to the growth of our progressive dividend from 5% to 7%. In the near term, our priority for capital deployment is to execute our organic growth plan. We continue to invest in our people, technology, and capability to enable our AUKUS strategy, including delivering US growth from our newly integrated US platform, driven by Avantus synergies. Finally, our strength and balance sheet gives us optionality for additional investment in sustainable growth and further shareholder returns. Stepping back, we have a clear investment case, which is unchanged. Our company is focused on our AUKUS customer's mission and aligned to structural growth markets, with our value proposition uniquely relevant to the enduring and increasing threat. By continuing to execute this strategy, we will achieve our guidance, as shown on the right of this slide, delivering high single-digit organic revenue growth at stable operating margin, with high cash conversion and attractive return on capital employed. We are well positioned for sustainable growth with compelling value creation for our shareholders. So, in summary, as the world continues to experience the threat, the highest threat environment for a generation, I'm incredibly proud of the outstanding skills and capabilities of our people, working in partnership to enable our customer's mission. Building on our excellent track record, we have delivered a further year of strong group financial results. We enter FY 25 with momentum and increasing spending in our major markets, giving us confidence to increase our guidance and underpinning the delivery of GBP 2.4 billion of organic revenue at approximately 12% margin by FY 27. With a strengthened balance sheet and an enhanced focus on disciplined capital allocation, we have optionality for additional investment in sustainable growth and further shareholder returns. In summary, we're well positioned and have a clear strategy to deliver another year of growth and compelling value for our shareholders. Thank you, and Heather and I would be happy to take any questions. Thank you, Steve. Thank you, Heather. We'll start with questions in the room before we go to questions that are online. When you ask your question, if you could just give your name and the company you work for, that would be great. Thank you. Thank you. Sash Tusa from Agency Partners. I wondered if you could just talk about cash flow, and particularly where the beat came compared to your expectations. Is it reasonable to think that because your performance in term-- your revenue performance, certainly at services, was better, a disproportionate amount of the extra cash came because of that, or is it more broadly split between the two divisions? I think maybe I could say a few words- Yeah, that's fine. And then, Heather, happy to be... I mean, I think if you just look back over history, Sash, we've actually had strong cash conversion. It's one of the, you know, fundamentals of the business, which I think is well regarded. And I think we've been consistent in delivering high cash conversion over many years. Our rolling guidance is always at 90% plus. But, you know, I think this year we delivered 104%, last year was 106%. So yes, a beat to our rolling guidance, but just based on our consistent and rigorous program management and cash management. So, you know, nothing different to just good, solid program execution in my mind. But, Heather, do you want to add anything on segmental? I think so. I mean, we manage our cash as on a group basis, as I think you'd expect, rather than looking particularly segmentally. I think all business units continue to contribute to cash performance on a very strong basis. Does that answer your question, Sash? Not really. Okay. I think I may have phrased it wrongly. Okay. Cash flow was very, very tilted to the second half. Yeah. I wondered what changed in the second half? Okay. Where did it change the most? Yeah, I think over the whole year... Is the mic still working? Yeah? Yeah. Over the whole year, you know, there was no change. It's consistent with our track record. I think in the half, yes, we were down at the half, and I think we said there was just some timing, you know, issues around some program deliveries and some cash receipts. So I think, as we said at the time, you know, there was no concern or worry to be had at the half, and I think we've just proven that out, and I wouldn't expect any fundamental repeat of that in future years. You know, we have got consistent delivery in our programs, and we'd expect our normal split, half to half. ... Okay, so, I mean, the first half of this last year was very much a one-off in terms of- It was a one-off. Great. That's exactly the way to think about it. Thanks. Sorry, I missed the point of your question. No, I think I missed stating it actually. Morning, Richard Page from Deutsche Numis. A couple from me, please. First of all, UK Intelligence contribution within a really strong performance mean your services stepped up again. Could you just give us a bit more on, on that and outlook there? And on the by the same token, on the US, lots of moving parts within there, CRS-I roll-off, Avantus, and, and what's happened ultimately in FY 2024 and what the outlook is within the US, particularly obviously post the continuing resolution roll-off election year, please. Two simple questions. How long have you got? I'm trying to think of a difficult financial one for Heather. Okay. Rich- Well, if you have got one, can you say it now so she can think about it? Yeah. Well, well, first of all, I mean, if you go back to, you know, our Capital Markets Day in, in New York, and we had James Willis, our chief exec for UK Intelligence on the stage, I think we started to reveal a lot more about our UK Intelligence sector, and I can't remember exactly the number, but it's a 20-plus% growth in its period, or over the last five years, sorry. And I think that team in UK intelligence is doing, you know, a really great, you know, job. It's really, as I said in my presentation, embedded, you know, both with our defense customer and our intel customer. Some really strong, you know, programs delivering, you know, further momentum. Specific that I mentioned was what's called the Socrates Program, where we're transforming, you know, the production of mission data for all UK platforms. Yeah, and that program's doing exceptionally well. So I think the underlying position that we have got in our UK intel, you know, business is exceptionally strong. In fact, if I bridge from that to your second question, if you actually step back and think about U.K. intelligence and U.S., and you may have noted, I used the phrase, "Yeah, and we now have, you know, an embedded position in the U.S." If you actually add up our, you know, intel business in this similarity, yeah, between U.K. intelligence and what we do in the U.S., with something of the order of, you know, GBP 900 million plus of our revenue, you know, is what you might want to call, you know, a data intelligence or cyber and data intelligence business, or C5ISR, whichever terminology you want to refer to. So we are now big in both, you know, the U.K. and U.S. I think that, you know, as you grow in scale, maybe some of the sort of high rates that we've had at 20%+, you know, organic growth will peter out. You know, but with two strong embedded positions, we'll expect that to really underpin, you know, the sustainable growth that we've got within our outlook and really gives us confidence in the, you know, the contribution to the GBP 2.4 billion, you know, organic growth through to FY 2027. Maybe specifically on the US comment, and gives me the opportunity to expand a little bit about what happened in the year. I mean, I think we all recognize and we've discussed openly, you know, that, you know, Avantus was lower than we all expected, and I think we addressed that in the, you know, the first half results. And, you know, a large factor in that was, as I said in the presentation, you know, a longer and deeper continuing resolution, you know, than, you know, a very long period of time, and one of the largest on longest on record. But the business has done really well, you know, and, you know, the team there have worked really hard. Avantus secured, as I said, $977 million of total contract awards. You can effectively think that it worked through a recompete season, you know, and won all bar one, I believe, of its, recompetes. That creates a really strong, you know, foundation, you know, with that backlog. It ended with a book-to-bill, as I said, just over, you know, 1.2. The second half grew, on the first half, modest growth, in the second half versus the first half, and with that backlog, and book-to-bill that I've mentioned, you know, now establishes, Avantus, you know, back on its trajectory. You know, mid-single digit, as Heather said in her presentation for the year, we're now in, you know, and back to double digit, yeah, in 2026 and beyond. So, you know, Avantus, yeah, really sort of integrated, you know, and now on its, growth trajectory. And I think now we need to look at it completely as an integrated U.S. platform. You know, we have a really strong team. We strengthened the business development, you know, team during the course of the year, you know, that I mentioned. We have a really clear strategy, you know, four primary revenue streams that are directly aligned to the U.S. National Defense Strategy. The first of those revenue streams is really what we would call, you know, persistent surveillance. The TARS program is a brilliant example of that. As I mentioned in the presentation, you know, there is no way that our Avantus, in its own right, would have won that program. The U.S. team couldn't have. It's part of the combination, the power of the combination really enabled us to win that program. What's our guidance? I would say if the US is prudent, you know, if I take that example, and I mentioned on contract growth, we can see on that particular program, you know, approximately 50% on contract growth, you know, coming, you know, in the next couple of years. That's, you know, the first revenue stream. I think the second revenue stream is we're sort of focused on our core DNA in the US, which is R&D. If you go all the way back to you know, the origin of our US, when the company, well before I was here, acquired Foster Miller, it was an R&D and innovation. You may have heard that theme, you know, coming through in today's presentation. you know, and the leverage of, you know, our technology solutions, part of the team up in Boston and what we acquired with, you know, MTEQ and its advanced sensors. You know, we're focused on core, you know, R&D. We have really good news, you know, this week. You know, one of our programs that we announced last year, NGATS, you know, to Heather's point about incremental funding, has just landed its next major block of incremental funding. So that's R&D. The third area of our focus in the U.S. is really around, you know, autonomous systems. Something we've got a strength on in the U.K., and the example that I gave at the beginning, Robotic Combat Vehicle, is a great example, and we're well positioned. And then the final one is exactly where we just started the question, cyber and intelligence. In fact, we've had some, you know, positive news there based on the platform. You know, we've just won two IDIQ positions with two completely new intel customers, NRO and NGA, which is, you know, you know, really great to start to see the benefits of why we acquired Avantus, a great business, why we've fully integrated it, and why we're confident in the growth coming through. I could talk all day about this, Rich. Does that answer your question? I think that's pretty comprehensive. Thank you, Steve. Sorry. Before we take the next question, can I just remind those who are online, if you have any questions, we've got over 100 people watching online. If you have any questions, please just use the phone line provided to ping them through. Thank you. Hi, thanks. David Farrell from Jefferies. A couple of questions from me. I can't help but notice you, you were stripping out the MSCA contract, to give kind of a view of the underlying performance. Then when we look at global solutions, there's, quite a few large contracts in there, $a few hundred million for five-year contracts. Just wondering what the repeatability is of securing contracts like that in global solutions. Would you like to describe the MSCA point first, Heather? Yeah, so I'll probably go to that first. So I think there is a key difference in the way that we, the orders are won and funded between the U.K. and the U.S. So on the MSCA piece, we won the GBP 260 million order last year, and we booked it, and hence it's within the orders. With those larger U.S. orders, they are large 5-year deals. However, we only, we only fund, they're only funded incrementally year by year, so within the orders number, there is only one year worth of the one year being funded. So I think that's probably the key difference to start with in terms of those big U.S. orders. Yeah, and I think, you know, David, if I could just sort of make a couple of points and maybe build back up to the future. Yeah, EMEA is in a really great position. And as Heather presented, I think it does make sense to do a comp of the 1.04-1.17, because a 10-year contract is a distorting factor. And I think we all know that, you know, order intake is a lumpy business. So I think that gives a better comparison for EMEA. And I think that if you look at some of the positions that we have within EMEA, we are absolutely growing. You can see it on, you know, some of the data that we've give. We are growing the number of larger, long-term contracts, so our position, you know, on those big service contracts is expanding. So we're very confident in the underlying sustainable growth, you know, of EMEA in line with the guidance that we're giving. I think secondly, to Heather's point about the additional disclosure, you know, in the U.S., I remember in this forum describing this at least for about two years when we were much smaller, you know, in the U.S., maybe when we were, like, $150 million. This concept that, you know, not concept, this practice that the U.S. fundamentally contracts in a different way to the U.K. So this notion of you win, you get a multi-year contract, and then you have this incremental funding, you know, that has to get appropriated and authorized, you know, each year, it's completely normal practice. So we consciously decided that after the full year, first full year of integration of Avantus, and now we have scale in the U.S., we don't want, you know, shareholders to have a distorted understanding of either our backlog or our pipeline opportunity by only seeing, you know, the value of our funded first year of contract awards. Yeah, and some of the numbers are quite material. You know, you take our current backlog of completely funded at GBP 2.9. If you add in, you know, back to the really great progress of U.S. order intake, you get to GBP 3.7... So I think, you know, in terms of that repeatability and onward momentum, you know, we're in a very strong position. And then just add, because I've certainly come up once in this presentation, add the pipeline. You know, the pipeline, we're over GBP 11 billion, and that's just what we're seeing in terms of funded. We haven't given an unfunded number on that. So if you start to factor in that on top of backlog, you sort of more than get the cover to both the EMEA and the global solutions guidance that we've given. Yeah, perfect. Thanks. Second question. You referenced it a couple of times, the continuing resolution in the U.S. and how that impacted the business. Are there any learnings you can take for the next almost inevitable continuing resolution as to how you would manage the business? Yeah, I think the answer is quite simple. We did learn from it, and we factored prudency into our guidance. If you look at the guidance for Global Solutions, and our U.S. business sits within Global Solutions, you know, stable performance is about building in prudency, you know, on a strong finish, you know, to the year in terms of backlog and book-to-bill, to make sure that, you know, we've got an election in the U.S. You know, it may go into another continuing resolution, so we've built more prudency into our guidance. That's the primary learning. Okay, so it's more about kind of financial guidance as opposed to day-to-day running of the business that you could take something away from? Yeah, well, that's the guidance comment. So in terms of the business, I think I've referred to the two primary learning points. We've absolutely integrated, we've strengthened the BD, and our focus of our programs is more directly aligned to the U.S. National Defense Strategy. So we're part of, you know, budget streams that are growing. They're coherent with our overall group strategy. So yeah, there's learning in terms of strategy and business operation, and at the same time, there's learning in terms of prudence within our financial guidance. Great, thanks. Hi there. It's Joel Spungin here from Investec. I'm not as familiar as many of the other people in this room with your business. I'm still getting to learn it, so forgive me. But I was wondering if I could start by asking about M&A. I guess specifically with the integration of Avantus now complete, do you feel that you are ready to take on another material deal? And maybe related to that, are there any comments you can make about pricing for potential targets in the market? Yeah, that's a really easy question because, you know, I think I said it in our presentation, during the course of the year, we've really enhanced our focus on capital allocation. And our near-term focus is absolutely on organic growth and making sure that we deliver, you know, all the way through to our GBP 2.4 billion target by FY 2027. It's true that we have a strengthened balance sheet and part of the enhanced focus on capital allocation, that does give us optionality to invest in the business, but it also provides optionality for further, you know, returns to shareholders. And as I mentioned, during the course of the year, we consciously chose to increase, you know, shareholder return. We launched the GBP 100 million buyback. As Heather said, we continue to see, you know, buybacks as part of, you know, our ongoing consideration of options within our capital allocation, and we've also increased, that we've announced today, you know, the increase in our progressive dividend. So I think, you know, if we step back, you know, and look at, yeah, while we might have got a long-term strategy, you know, for further growth, our clear near-term focus is on the organic plan. Is there any comment you can make about sort of pricing on potential targets or anything like that? Has that changed? I mean, more generically, I mean, I don't think the dynamics on pricing of targets has really changed in the last few years. You tend to see, you know, higher multiples in, you know, the U.S. versus Europe. I think those, those dynamics, you know, broadly remain constant. Thank you. Just maybe one, one quick one. Sure. You mentioned about LTPA. Is there any risk around that, or is it highly likely that that will be extended to 2033? So if you're sort of new to the story, the current contract, which was a 25-year contract, currently runs through to 2028, and in November just gone, we announced that we had signed a principles agreement with the UK government, you know, to work through a negotiation that would take that through to 2033. And as I mentioned in the presentation, you know, those discussions are going well. We're absolutely on track, and I would expect early in 2025, that that contract extension would be signed, and that will provide services through to 2033. Thank you. It's Sash Tusa again. I wonder if I could just ask a question about robotics and sort of compare and contrast with targets. The targets business is clearly a production business, and you said volumes are extraordinarily high at the moment. Robotics still seems to be, and this seems to be a generic across the industry. I don't think this is a QinetiQ issue, but it's a series of one-off contracts that occur, vanish, occur, vanish, and it-- there doesn't seem to be a stability in the business. Is that because customers still haven't worked out what to do with these things? ... Yeah, I think you actually make a fair point. And actually, as I'm thinking about the answer, I think we're actually seeing a changing dynamic between robotics and targets, Sash. I think, you know, if you look at some of the dynamics, I think in one of the questions earlier, yeah, we've seen, you know, our small robot program called CRS-I, you know, plan its ramp down. It sort of reached sort of peak production and then has faded down. That's one of the, you know, sort of underlying drivers for some of the, you know, the sort of reduction in revenue in our legacy U.S. business, and that will continue and come to a conclusion, in fact, it already has in this year. So we'll see that step down to completion when we compare FY 2024 results to what we deliver in FY 2025. But I think what we are seeing in robotics, and it's also a conscious choice for ourselves, that we're progressively moving up the value chain to the higher layers of intelligence of... And you see it, we're actually calling it autonomous systems, you know, more than robotics. And if you look at our role with Oshkosh on the Robotic Combat Vehicle, you know, we're doing the autonomous systems layer, you know, the networks, you know, the algorithms, the integration, the safety, you know, those are the higher value. We're not doing the core manufacture of the platform. So I think it's true to say that, you know, the lumpy nature, as you sort of alluding to, of the core robotic platform, I mean, is a feature of this marketplace. But we're offsetting that by moving up the value chain into a more enduring role around autonomous systems. I think with targets, I think it is a little bit different. I think we're actually seeing exceptional demand, you know, in targets, which I would broaden out to threat representation. You know, we have airborne training services, we have targets, we have, you know, digital and simulated training services. I think that, you know, current conflicts, you know, are really underpinning, you know, the need, you know, aligned with our value proposition, that you have to test, you know, the kit that you're taking into the field is gonna work as you expect. It performs, it's safe, it's interoperable, and therefore, the demand on training and mission rehearsal is, is growing, both from a production and a service-based point of view. And it's, it's partly why we've tried to, tried to simplify the understanding of QinetiQ again today by talking about, you know, core R&D, where all nations, particularly in AUKUS, are putting more and more into R&D, 'cause R&D is the way that you overmatch the enemy. They're putting more into T&E, because you have to know that the kit is gonna work safely and at the level that's gonna give you the operational edge. You have to be prepared and ready to fight. That's what training and mission rehearsal is, and cyber and intelligence is just growing, you know, it's not just the physical world. So they are the two dynamics, so I think it's a good spot, Sash. It's something of a dynamic that's changing in the company. Hi, David Farrell from Jefferies again. One, I think, for Heather. Just want to pick the organic revenue growth in EMEA Services a little bit. Firstly, kind of what element of that was pricing versus activity levels? And then kind of second question is, what kind of headcount growth was there in EMEA Services last year? Headcount growth in EMEA Services- Let me say a few words. You say a few words while I just find my background. I mean, the first thing I would say is that, I mean, we're really pleased with EMEA growth. I mean, EMEA, you know, delivered really good performance, and the primary drivers for that were an exceptionally strong prior year. I think if you go back to our FY 2023 results, you know, we had an overall, yeah, book-to-bill of 1.4. So during the course of the year, EMEA, you know, the teams did an outstanding job executing, you know, those orders. We also, on the back of operational tempo, had increasing, you know, demands, you know, during the course of the year. That again, you know, the team did execute. Part of that was delivered through, and we'll see, you know, some increases in headcount. You know, and those are the primary drivers. There were some inflationary benefits, as we've talked about, you know, before. You know, we have got contracts where we get some inflationary, you know, benefit, but the primary driver, you know, for the growth really was the strong prior year orders, yeah, and some of the increasing demand that came through in the year. Yeah, so, I mean, to build on that, in terms of the growth, I think, you know, probably only sort of a couple of percent, 2%-4% probably coming through inflation. In terms of the underlying, you know, delivery, a lot of it was through delivery from our people. Back to that headcount question, headcount actually increased 8% year-on-year within EMEA Services, so a lot of it coming through core project delivery through our people. Great answer. Thanks. Okay. Thanks. Okay, thank you. I can see that there are no questions online, so if there are no final questions in the room, then Steve, maybe a closing remark if you, if you fancy? Yeah, great. Well, thank you, everyone, for your questions. I mean, maybe, maybe we should just finish. Yeah, we're really pleased with the results. We got really good momentum. We're absolutely on track for GBP 2.4 billion. The level of organic growth that we need to achieve, if you've done your sums, is now 8%. It's bang on in the middle of our guidance. Last year, it was 9%, so confidence is increasing, and also we've got, yeah, a much greater focus on capital, you know, allocation. That's all about optionality to invest in the business, and options for further shareholder return. So thank you for your time, and, if you've got any follow-up questions, Heather and I will both be very happy to answer them. Thank you. Thank you very much.